Introduction
Those who refuse to go beyond fact rarely get as far as fact.
T. H. Huxley (Taylor 1970) I was invited to write about the discovery of Nerve Growth Factor and its relationship to developmental neurobiology. Rather than detail the life of NGF over the past 30 years, I wish to concentrate on what was the most attractive and also the most unusual feature in the investigation of NGF: that each finding has signaled a new turning point and opened up a new perspective. The story of NGF is therefore more like a detective story than a scientific enterprise, since science usually unfolds according to welldefined rules, along the route paved by previous findings. In retrospect, the previous experience with NGF holds out the promise that as many turning points still await us on the road ahead as we experienced on the road we have traveled so far. To me this is an encouraging rather than a depressing thought; the abrupt end of a scientific pursuit is more often synonymous with an intellectual dead end than with a goal successfully achieved. By way of introduction, I shall recount the early beginnings of this research, which are well known to old-timers but probably not to biochemically trained newcomers who were lured to take part in this game by the molecule itself and who are .only vaguely acquainted with its natural history and with its problems.
1951: The Beginning of a Long Journey
In the Fall of 1951, Nerve Growth Factor, then still unnamed and chemically unidentified, was introduced to the public for the first time at a conference on "The Chick Embryo in Scientific Research" held at the New York Academy of Science (Miner 1952) . One of the topics discussed at that meeting was the effects of chemical agents on tumors (from birds and mammals) that had been transplanted into the body wall or onto the chorioallantoic membrane of chick embryos. The tumor and the embryo were partners, each feeding on the limited resources of the egg and growing according to its own vastly different program. Of the two partners, the tumor was usually the main object of interest. Elmer Bueker, a former student of Viktor Hamburger (the foremost authority in the field of experimental neuroembryology), inverted this trend (Bueker 1948) . He explored the changes that take place in the embryo that bear transplants of neoplastic tissues.
Bucker found that when dorsal root ganglia innervated a transplant of mouse sarcoma 180 that had been grafted into the body wall of three-day chick embryos, the ganglia became enlarged. This report did not stir the emotions of the neuroembryologists in attendance, accustomed as they had become to the extravagant performances of the developing amphibian and teleost nervous systems, that readily adapt even to the most bizarre demands that can be generated by the imagination of the investigator (Harrison 1935) . Even the discoverer of this remarkable phenomenon did not consider it unusual. Rather, he thought it provided additional evidence for the important role played by peripheral structures in promoting the growth and differentiation of the nerve cells that innervate these tissues. The increase in volume of sensory ganglia that sent nerve fibers to the tumor seemed to support the prevailing concept that the size of a developing nerve center is under the control of its field of innervation and seemed to emphasize the parallel between the effects elicited by neoplastic tissue and those elicited by transplanting an extra limb rudiment. Bueker's observation also supported the hypothesis that nerve fibers channel the trophic agent synthesized by target tissues toward the cell bodies of the neurons.
Comparison of the transplanted supernumerary limbs and the transplanted tumors did bring to light some discrepancies, however, and suggested to me and to Viktor Hamburger that this phenomenon needed to be investigated in more detail. Using a silver staining technique specific for neurons, we traced the nerve fibers from their cell bodies of origin to their peripheral targets. By this means we uncovered new aspects of the effects elicited by the tumor that differed markedly from those produced by grafting additional limb rudiments. In two-to three-week old embryos bearing neoplastic tissue to establish contact with it, invaded the viscera in large numbers. These fibers also invaded the blood vessels, and in some instances obliterated the lumen of these vessels. Similarly, chaotic and highly aberrant peripheral distribution of sympathetic nerve fibers was found in embryos in which the mouse sarcoma was transplanted onto the chorio-allantoic membrane in a way that prevented direct contact between the embryonic and the neoplastic tissues. Based upon these findings, I proposed the hypothesis (presented at the New York Academy of Sciences conference) that the tumor released a humoral factor which gained access to the ganglia through the circulatory system (Levi-Montalcini 1952) . This initial hypothesis was soon supported by further experiments.
THE FIBRILLAR HALO If the tumor releases a diffusible factor, tumor extract might be expected to work as well as the implanted tumor. We failed to replicate the effects of actively growing neoplastic cells by injecting tumor extract, however, and this suggested to me the alternative possibility of studying the effect in tissue culture. In 1952 tissue culture was still an amateur's tool. Rather than being used to study basic biological problems, it had been used primarily to satisfy the biologists' curiosity and esthetic pleasure by permitting one to watch cells proliferate and axons elongate and branch. I came to the idea of studying this effect in culture only after injection of extracts derived from the tumor had failed to produce results. We did not have tissue culture facilities at Washington University, but I knew that my friend, Hertha Mayer, had established an efficient culture facility at the Institute of Biophysics of the University of Rio de Janeiro, directed by Professor Carlos Chagas. In the Fall of 1952, following an exchange of letters and an invitation from Professor Chagas, I boarded a plane for Rio de Janeiro, carrying in my handbag two mice bearing transplants of mouse sarcoma 180 and 37.
The outcome of the experiments performed in that most attractive and hospitable milieu was so clear as to require only a few words of comment. As I wrote in a previous article, "The tumor factor had given a first hint of its existence in Saint Louis but it was in Rio de Janeiro that it revealed itself, and it did so in a theatrical and grand way, as if spurred by the bright atmosphere of that explosive and exuberant manifestation of life that is the Carnival in Rio" .
When sensory and sympathetic ganglia from eight-day chick embryos were cultured in a semi-solid medium close to fragments of mouse sarcoma 180 or 37, they produced a dense halo of nerve fibers in 12-24 hours. This discovery marked still another turning point. It offered the possibility, unattainable in developing embryos, of performing biochemical studies on the tumor factor. This rapid in vitro bioassay also offered the possibility of www.annualreviews.org/aronline Annual Reviews screening other tissues and organic fluids for potential sources of growthpromoting agents. The discovery of two of these sources materialized shortly and fulfilled our hope far beyond expectation. The same technique later provided a valuable, and, in fact, the only way for discovering other specific growth factors, opening new and promising areas of research.
I reported the in vitro effects elicited by the two mouse sarcomas that same year at the Academy of Sciences in Rio de Janeiro and again one year later at a Cell Biology Symposium in Copenhagen (Levi-Montalcini 1953) . I also presented a detailed description of the fibrillar halo in a subsequent article . Stanley Cohen, a gifted, young biochemist, who joined our group in St. Louis in 1953, soon identified the humoral factor released by the two mouse sarcomas in a nucleoprotein particle. This factor was christened Nerve Growth Promoting Factor, a name we later shortened to Nerve Growth Factor (NGF) (Cohen et 1954) .
SNAKE VENOM AND THE MOUSE SUBMAXILLARY SALIVARY GLANDS In 1956 and 1958 we discovered that the most potent sources for NGF were in snake venom and the submaxillary salivary glands of the mouse (Cohen & Levi-Montalcini 1956 , Cohen 1958 , Levi-Montalcini 1958 ). Cohen played a major role in these apparently casual but brilliant discoveries. He identified the NGF of snake venom and of the mouse salivary glands in two protein moieties, both of which were found to possess biological and biochemical properties remarkably similar to the NGF of mouse sarcomas. Recent studies have provided new evidence to support this point (Barklis & Perez-Polo 1981) . The discovery that NGF is synthesized in the collecting tubules of the salivary glands (Levi-Montalcini & Angeletti 1961) and that the synthesis is controlled by testosterone (Levi-Montalcini & Angeletti 1964 , Ishii & Shooter 1975 and by thyroxine (Aloe & LeviMontalcini 1980) has contributed further to the studies of NGF.
Despite an active search for alternative sources rich in NGF (Harper et al 1979 , Harper & Thoenen, 1980 , Goldstein et al 1978 , the mouse salivary gland remains the richest source. It has supplied the purified NGF needed for structural studies as wall as for the exploration of its mechanism of action.
MAIN FEATURES OF THE GROWTH RESPONSE ELICITED BY THE SALIVARY NGF We carried out morphological, ultrastruetural, and biochemical experiments on the growth response elicited by the salivary NGF. The main features of these effects are summarized as follows:
NGF elicits the formation of the nerve fibrillar halo at a concentration of 1-10 ng/ml of culture medium within 10 to 24 hr. Higher doses result www.annualreviews.org/aronline Annual Reviews in a change from a radial to a circular pattern of nerve fiber outgrowth . The recent experiments of Rutishauser & Edelman (1980) have offered an explanation of this effect. In the absence of serum and NGF, dissociated nerve cells in culture undergo deterioration and death within 24 hr. When I0-I00 ng/ml of NGF are added daily to the medium, the cells survive indefinitely, and build a dense nerve fiber network (Levi-Montalcini & Angeletti 1963) .
Daily injections of NGF into neonatal rodents for two weeks result in a six-to nine-fold increase in volume of sympathetic ganglia compared to untreated age-matched littermates (Levi-Montalcini & Booker 1960a) . This overgrowth of the ganglia to prolonged exposure to exogenous NGF is due to enhanced differentiation, overproduction of axonal material, and prevention of natural death, which cause the loss of a large number of differentiating nerve cells in control rodent pups (Hendry, 1977) . Electron microscopic studies in vitro and in rive showed that the earliest effect elicited by NGF is a massive increase in microtubules, neurofilaments, and microfilaments .
Metabolic studies on dissociated embryonic sensory cells exposed, to NGF for 8 hr showed that all anabolic processes are markedly enhanced; there is increased incorporation of labeled precursors into proteins, lipids, and RNA, but not into DNA.
THE PRIMARY STRUCTURE OF NGF Studies
on the physico-chemical properties of NGF first performed by Cohen (1960) were continued different laboratories. The biological and structural properties of two forms of NGF--a high molecular weight and a low molecular weight form (which became known as 2.5 S and 7S NGF on the basis of their sedimentation constants)--have been discussed in several articles (Angeletti et al 1967 , Zanini et al 1968 , Bocehini & Angeletti 1969 , Varon et al 1967 . The two populations of NGF result from different techniques used in purification: the high molecular form of NGF consists of other subunits besides the active NGF moiety; it does not differ from the 2.5 S NGF in its biological activity. The procedure devised by Bocchini & P. Angeletti provided purified NGF that was used in 1971 by R. H. Angeletti & Bradshaw to elucidate the primary structure of the 2.5 S NGF. Their studies showed that it consists of two identical monomers held together by noncovalent bonds. Each monomer consists of 118 amino acid residues and has a molecular weight of 13,250 ( R. H. Angeletti & Bradshaw 1971) . The significance this feat is apparent. It achieved a goal set two decades earlier when the growth effect elicited by the two mouse sarcomas was traced to an unidentified humeral factor released by the neoplastic cells. Purification of NGF signaled the beginning of investigations directed at answering an increasing number of questions that have not yet been totally resolved. Other features of the NGF-target cells interaction, not foreseen at the end of the second decade, were to emerge at the forefront of the field, opening ncw perspectives and initiating new studies.
DESTRUCTION OF THE PARA-AND PREVERTEBRAL SYMPATHETIC CHAIN GANGLIA WITH ANTISERUM TO NGF In 1959 Cohen produced a specific antiserum to NGF (Cohen 1960) . Adding the antiserum the culture medium totally prevented the formation of the NGF fibrillar halo. The antiserum (AS-NGF) was next assayed by injecting it into neonatal and adult rodents and other mammals. In neonatal rodents AS-NGF produced massive destruction of the adrenergic neurons located in the paraand prevertebral chain ganglia (Levi-Montalcini & Booker 1960b) . However, nerve cells of the sympathetic ganglionic complexes positioned close to their end organs (genital system, brown adipose bodies in rodents and heart tissue) are not receptive to the growth-promoting activity of NGF nor are they vulnerable to the NGF antiserum (Levi-Montalcini 1972) . This treatment, known as immunosympathectomy, does not interfere with the vitality and the normal development of the injected pups (Levi-Montalcini & Angeletti 1966) . The availability of the antiserum to NGF made it possible to study adult rodents deprived from birth of the function of the sympathetic para-and prevertebral ganglia (Steincr & Sch~inbaum, 1972) .
Two candidate mechanisms were considered as causing the destructive effects of NGF antiserum on immature sympathetic nerve cells: (a) a cytotoxic complcmcnt-mcdiatcd cell lysis or (b) a dcprivation of cndogcnous NGF through inactivation by the injected antiserum. The second mechanism has been strongly supported by the recent demonstration that administration of NGF (even when given 24-48 hours after antiserum) reverses the otherwise deleterious effects produced by NGF antibodies (Thocnen ct al 1979, Harper & Thocncn 1980) . Whereas immature sympathetic nerve cells arc destroyed by antibodies to NGF, the same treatment produces only moderate and largely reversible damage to the sympathetic neurons of adult rodents (Levi-Montalcini & Cohen 1960) . www.annualreviews.org/aronline Annual Reviews I.The molecular size and subunit composition of the biologically active NGF. 2. The processing of active NGF from a large molecular weight precursor. 3. The cffects of modifications of single amino acid residues on biological activity. 4. A comparison of the primary structure of NGF with insulin. 5. The non-enzymatic properties of the biologically active NGF. 6. The evolutionary history of the NGF molecule (as evaluated by structural and immunological studies).
1972-1981: The Road Ahead and the Everchanging Panorama
The extensive literature on these topics is reviewed by investigators actively cngagcd in this area (Angclctti ct al 1973 , Varon 1975 , Bradshaw 1978 , Moblcy et al 1977 , Thocncn et al 1979 , Thocncn &Bardc 1980 , Grccnc& Shooter 1980 , Harper & Thocncn 1980 . When NGF binds to receptors at the nerve endings of the target neurons, the NGF is internalized and carried by retrograde axonal transport to the cell soma where NGF is still biologically active (Hendry et al 1974 , Paravicini et al 1975 , Stoeckel et al 1976 . There are also receptors to NGF or the pcrikaryon. NGF that binds to these ceil body receptors also undergoes internalization (Yankncr & Shooter 1979 , Calissano & Shelanski 1980 , Biocca et al 1980 . These findings raised the question: Is internalization instrumental in the activity of NGF?. If so, what are the intraceilular targets of NGF? Three main hypotheses are under investigation. '
1. NGF acts on the plasma membrane and its effects are mediated within the cell through a second messenger. In this case, internalization might only serve to channel NGF toward lysosomes for degradation. The failure to find clearcut changes in the concentration of the classical second messengers (cAMP and cGMP) argues against this hypothesis.
2. NGF acts through multiple sites, some located on the plasma membrane and others present in intracellular organelles. Receptors located on thc plasma membrane could alter membrane permeability or produce other surface events, a possibility favored by Varon and associates (Varon 1975 , Skaper & Varon 1979 , Varon & Skaper 1980 . Intraceilular sites either on the nuclear membrane or inside the nucleus 0fankncr & Shooter 1979, Marchisio et al 1980) could mediate the effects of NGF on gene expression. In addition, NGF could act on receptors on the cytoskeleton (Calissano www.annualreviews.org/aronline Annual Reviews Cozzari 1974, Levi ct al 1975 , Calissano ct al 1976 , Calissano et al 1978 and produce postranscdptional molecular events that lead to axonal growth.
3. NGF directly controls gent expression. There is as yet no evidence to support this hypothesis, but Greene has recently proposed a model for the action of NGF consisting of transcription-dependent and transcriptionindependent events, the former occurring in pro-differentiated state, the latter occurring after differentiation of the target cell (L. A. Greene, D. Burstcin, M. Black 1980) .
The end of the third decade of studies on NGF marked a renewal of interest in problems that had been previously neglected. Previous efforts had been directed primarily toward elucidating the structural properties of NGF and its interaction with its target cells. Chance, rather than planned research, brought some of these problems back to the forefront opening new vistas and reviving the old, traditional adventerous spirit. The next section surveys the new areas that have a direct bearing on NGF and developmental neurobiology.
THE TROPHIC, TROPIC, AND TRANSFORMING EFFECTS OF NGF
The magnitude of the growth effects elicited by NGF on intact immature sympathetic nerve cells raised an important question. Would this molecule also exert beneficial effects in cells lethally injured with antiserum to NGF and to other pharmacological agents, such as 6-OHDA, which lead to their massive destruction? In all instances the protective effects of NGF were far above our expectation. The combined treatment of neonatal rodents with 6-OHDA (which destroys noradrenergic neurons) and with NGF not only protects the sympathetic neuron but actually resulted in a 30-fold increase in volume of sympathetic ganglia compared to the ten-fold increase produced by NGF alone , Aloe et al 1975 . Structural and histottuorescence studies provided an explanation for this paradoxical finding. NGF does not prevent accumulation of 6-OHDA in the adrenergic nerve endings and their destruction by this toxic compound (Thoenen & Tranzer 1968) . (This effect is counteracted, however, in that NGF gains access to the cell perikarya, either directly through membrane receptors or through intact preterminal endings.) The exogenous NGF supply, far greater than the NGF that normally reaches the call body through retrograde axonal transport in intact cells (Hendry et al 1974) , enhances all metabolic processes and results in the exuberant production of collaterals from the proximal segment of the axon. This process also largely accounts for the enormous volume increase of the ganglia. A similar though lesser effect is elicited in surgically axotomized nerves of the superior cervical ganglion in neonatal rodents (Hendry & Campbell 1976) . Surgical axqtomy also prevents NGF entrance from peripheral tissues and leads to www.annualreviews.org/aronline Annual Reviews death of 90-95% of immature sympathetic nerve cells in superior cervical ganglia. This death is counteracted by exogenous NGF (Hendry 1975 , Aloe & Levi-Montalcini 1979 . NGF also counteracts the destructive effects of guanethidine in sympathetic ganglia by calling forth an overgrowth of these ganglia not exceeding that produced by administration of NGF alone (Johnson & Aloe 1974) . A third agent, vinblastine, exerts its action interfering with the assembly and function ofmicrotubules. The destruction of sympathetic ganglia by vinblastine is likewise prevented by simultaneous administration of NGF (Calissano et al 1976 , Menesini-Chen et al 1977 , Johnson 1978 . 1 A unifying hypothesis that explains the ability of NGF to counteract antiserum to NGF, noxious agents, as well as the effect of axotomy, is to attribute cell death in all of these instances to deprivation of the cells of NGF. This deprivation is achieved by different mechanisms, however, such as inactivation of circulating NGF (AS-NGF), blockage of its aeeess adrenergic nerve endings (6-OHDA) and surgical axotomy, and prevention of NGF retrograde axonal transport (vinblastine). The only treatment which the protective effect of NGF remains to be clarified is that with guanethidine .
THE NEUROTROPIC ACTIONS OF NGF The initial discovery that nerve fibers from sensory and sympathetic embryonic ganglia placed near an NGF source (mouse sarcoma) in vitro direct their course toward it suggested that NGF could also exert a neurotropic action. This effect has been unequivocally proved in recent years in different in vitro and in vivo systems (Charlwood et al 1972 , Chamley et al 1973 , Menesini-Chcn et al 1978 , Levi-Montalcini 1978 , Campenot 1977 , Letourneau 1979 , Gundersen & Barrett 1979 , Rutishauser & Edelman 1980 . The main findings are outlined as follows:
Experiments in vivo Daily intracerebral microinjectious of NGF near the two loci cocrulci in neonatal rodents repeated for ten days result in an increase in volume of sympathetic ganglia comparable to that elicited by systemic NGF injections. In addition--and at variance with the effects of systemic NGF the intracerebral administration of NGF results in the penetration of large sympathetic fiber bundles into the spinal cord and their growth in the brain stem toward the point of injection. The existence of these adrenergic fiber systems was asce~ed with hisThe protective effects of NGF against AS-NGF were documented by Harper and Thocnen (1981) .
www.annualreviews.org/aronline Annual Reviews tofluore~ence techniques and their origin traced to markedly enlarged paravertebral ganglia. Stem axons or, more likely, collateral nerve fibers sprouting from the main axon, assemble in bundles soon after they emerge from the ganglia. These fibers gain access to the central nervous system at the level of the spinal cord by adhering to the sensory dorsal roots. Once inside the spinal cord, they assemble in the lateral and dorsal funiculi where they persist as long as NGF is supplied by intracerebral injections. This highly aberrant and parasitic fiber system establishes no connections within the spinal cord or the brain, and upon termination of treatment is reabsorbed. These adrenergic nerve fibers are thought to be channeled inside the spinal cord and brain along a rostro-caudal diffusion gradient of NGF. This idea is supported by studies of the spatial distribution of labeled NGF at different times after the intracerebral injections.
Experiments in vitro
In an degant series of in vitro experiments, the growth of neurites from dissociated sympathetic nerve cells was shown to be controlled by NGF in the local environment. In a three-chamber culture system, nerve cells were cultured in the middle chamber, rich in NGF. The neurites produced by these cells crossed a fluid-impermeable barrier interposed between the central and the two lateral chambers. They branched only in the lateral compartment that also contained a medium rich in NGF. Removal of NGF from this compartment caused the distal portion of the neurite to stop growing and the fibers to undergo degeneration (Campenot 1977 ). In the experiments described by Gundersen & Barrett, axons from dissociated sensory neurons turned and grew toward the NGF solution released from a micropipctte. Dislocation of the the NGF-filIed micropipette resulted in a changed orientation of the growth cone, which directed its course toward the new position of the NGF source (Gundersen & Barrett 1979) . The relevance of these findings to problems of neurogenesis is considered in the last section.
A TRANSFORMING EFFECT OF NGF A new, most valuable model system for exploring the activity of NGF has resulted from the discovery that cells isolated from a rat pheochromocytoma tumor line (PC 12 ceils) and treated with NGF undergo transformation into nerve cells that are indistinguishable from typical sympathetic neurons in their morphological, biochemical, and electrical properties (Tischler & Greene 1975 , Greene Tischler 1976 , Dichter et al 1977 . Studies of this PC 12 cell line are mentioned above, since this line is ideally suited for investigating the NGFreceptor binding and internalization processes (Yankner & Shooter 1979 , Calissano & Shelanski 1980 , Biocca et al 1980 . A particularly useful feature of PC 12 cells is that the actions of NGF appear to be www.annualreviews.org/aronline Annual Reviews reversible (Greene & Shooter 1980) . Withdrawal of NGF causes neurites to disintegrate and cell division to recommence (Greene & Tischler 1976) .
More recently, a transforming effect of NGF has been described on normal adrenal chromaflin cells obtained from 10 to 12-day-old rats and cultured in vitro COnsicker & Chamley 1977 , Unsieker et al 1978 . This finding extended previous reports of the formation of nerve-like processes by adrenal medullary cells transplanted into the anterior chamber of the eye of a rat even in the absence of NGF (Olson & Malmfors 1970) and adrenal medullary cells carried in routine culture media (Manuelidis Manuelidis 1975) .
Recent studies performed in our laboratory have shown that NGF injections in 16-to 17-day-old rat fetuses, administered through the intact tubes and resumed immediately after birth, result in the massive transformation of chromaflin cells into sympathetic nerve cells. This effect produces dramatic changes in individual cells as well as on the adrenal gland, the paraganglia, and the carotid bodies (Aloe & Levi-Montalcini 1979) . The transformation is even more impressive when NGF injection starts in early embryonic stages (Levi-Montalcini & Aloe 1980) .
OM Problems and New Vistas
The beginning of the fourth decade of NGF studies welcomes a revival of interest in old problems and the shaping of new ones. I shall consider two of the old ones that have been with us ever since the beginning. They concern (a) the role of NGF in the differentiation of sensory nerve cells and (b) the functional significance of NGF produced by the salivary glands for the development of sympathetic nerve cells.
THE ROLE OF NGF IN THE DIFFERENTIATION OF SENSORY NERVE CELLS
In the analysis of the multiple effects of nerve growth factor (NGF), the sympathetic ganglia have played the dominant role; the sensory ganglia which are the other targets of NGF have attracted much less attention (Hamburger et al 1981, p. 60) ,
In an initial attempt to study the role of NGF on sensory ganglia in vitro, Brunso-Beehtold & Hamburger (1979) confirmed and extended the studies of Thoenen & Barde (1980) on the selective retrograde axonal transport 1251 NGF by nerve fibers of dorsal root ganglia in adult rats. BrnnsoBechtold & Hamburger showed that subcutaneous implantation of polyacrylamide gel pellets impregnated with 125I NGF in the leg often-day chick embryos results in heavy labeling of sensory ganglia innervating the leg (Brunso-Beehtold & Hamburger 1979) . In a subsequent study, Hamburger et al (1981) examined the effects of NGF on two neuronal cell populations found in dorsal root ganglia of chick embryos and distinguishable on a www.annualreviews.org/aronline Annual Reviews topographical basis: the dorso-medial (DM) and ventro-lateral (VL) nerve cells (Hamburger & Lcvi-Montalcini 1949) . These populations are easily distinguishable from one another on the basis of their time course of differentiation, their morphology, and their response to experimental decrease or increase in their peripheral field of innervation. Early studies on implantation of mouse sarcomas 180 or 37 showed a marked differential response to the tumors: only the DM cells underwent an increase in number and size and showed enhanced differentiative processes in embryos bearing these transplants (Levi-Montalcini & Hamburger 1951) . The concept that the DM but not the VL nerve cells are receptive to the tumoral NGF was now revised as a result of these new studies. Daily administration of NOF, supplied through injections in the egg yolk from the third to the twelfth days of incubation, counteracted neuronal death in both cell populations, (cell death in the two populations occurs at different times in development). The VL cells, however, unlike the DM cells, do not undergo striking morphological changes upon treatment with NGF in vivo or in vitro (Levi-Montalcini 1966) , and consequently NOF exerts its anabolic effects by promoting changes that are more subtle than in the DM cells and not as easily detected visually. This finding is of great interest since it shows that all sensory neurons respond to NGF, and that NGF can promote effects other than enhancing nerve fiber growth. This hypothesis is supported by other recent studies. As described above, the precursors of chromaffln cell respond to NGF even before they have differentiated into glandular cells. Melanoma cells that do not undergo clear morphological changes upon NGF in vitro treatment have NGF receptors on their cell membranes and undergo some biochemical changes (Fabricant et al 1977) .
THE MOUSE SALIVARY GLANDS AS AN ENDOGENOUS SOURCE OF NGF FOR SYMPATHETIC NEURONS There is still no satisfactory
answer to the much investigated question: Does the NGF synthesized and released from the salivary glands of adult mice play a role in the functioning of sympathetic nerve calls that respond in such a dramatic way to exogenous salivary NGF? Earlier results of several types of experiments , Hendry & Iversen 1973 , Thoenen & Barde 1980 do not reveal a functional role of salivary NGF with respect to sympathetic nerve cells. But recent data call for a revision of this hypothesis. NGF released from the salivary glands of adult male mice after injections of cyclocytidine, a pyrimidine nucleoside endowed with fl-adrenergic stimulant properties, markedly raises the level of circulating NGF. Sympathetic ganglia of mice injected with cyclocytidine undergo an increase in volume due to neuronal hypertrophy. Protracted treatment with eyelocytidine also www.annualreviews.org/aronline Annual Reviews enhances the speed of regeneration of surgically transected postganglionic nerve fibers (Levi-Montalcini & Aloe 1981) . Orally administered NGF also promotes overgrowth of sympathetic ganglia. This finding suggests that the NGF released into the saliva has a growth-regulating role not previously considered (Aloe et al 1982, submitted) .
A NEUROENDOCRINE ROLE FOR NGF'? Although injections of NGF in rat fetuses lead to the transformation of immature chromaffm cells in sympathetic neurons (Aloe et al 1975) , no somatic changes are apparent newborn rats. However, injections of a specific antiserum to NGF in 15 to 17-day-old fetuses and continued postnatally resulted in dramatic somatic and behavioral changes indicative of specific alterations of sensory primary neurons (Aloe et al 1981) . The effect of NGF antiserum in developing sensory neurons in turn produces a severe sensory deprivation syndrome consisting of unsteady gait and decreased sensibility to tactile and noxious stimuli (Aloe et al 1981) . Electrophysiological studies in rat pups injected with AS-NGF during fetal life showed marked depression of excitability of neurons innervating the leg muscles. However, no apparent changes were found in those innervating cutaneous tissues (Arancio 1981, unpublished results) . Destruction of sensory neurons in dorsal root ganglia in rats and guinea pigs, deprived of Nt3F during fetal life, was first described by Gorin & Johnson (1979) and Johnson et al (1980) . By using a different technique --that of injecting a specific antiserum to NGF in rat fetuses--we found that administration of NGF antiserum during fetal life results in depletion of sensory nerve cells in the spinal ganglia and in widespread signs of damage in the residual neurons.
Of particular interest is the finding that the same pups exhibited pronounced behavioral changes in addition to these sensory deficiencies. Neonatal rats injected with AS-NGF did not differ at birth from controls. The following two weeks marked a postnatal pefi0d during which time the infants exhibited a progessive loss of weight and refused to suckle. This resulted in the death of about 60% of the treated infant rats. Those who survived this early postnatal period showed a sluggish apathetic behavior and also differed from age-matched controls in their smaller size and weight. Histological studies showed a marked decrease in volume of the thyroid gland. Studies in progress are aimed at identifying the neuronal or n0n-neuronal systems that were damaged by the administration of the specific antiserum to NGF during fetal life. I consider the significance of this neuroendocrine syndrome again in the following and final section.
NGF and Developmental
Neurobiology at a Crossroad In 1951 a phantasmal and elusive NGF took us on a byway that departed from the main road, running across a rather dull and flat land. The narrow www.annualreviews.org/aronline Annual Reviews lane of NGF was now all the more alluring as it started winding through picturesque and ever-changing panoramas. Now, three decades later, NGF has joined the main road once again, presented with a splendid landscape. Although still partly hidden from view, it has heightened our anticipation of the possibilities that lie ahead. In this landscape, NGF has at last "found its place in the ever-changing game of the neuroscience chessboard" (LeviMontalcini 1975) . It has provided a most profitable approach to basic questions that are the main considerations in today's fast-growing field of developmental neurobiology. I do not consider here the most apparent and generally acknowledged merit of NGF, that it has provided a unique system for the exploration of processes of nerve cell growth and differentiation at different levels. Rather, I relate other contributions of NGF-targct cell interaction to our understanding of basic neurobiological problems.
THE HUMORAL AND AXONAL MEDIATED TRANSPORT OF TROPHIC FACTORS TO NERVE CELLS IS the effect of NGF on growth radically different from those produced by implanting leg buds or other embryonic tissues? Although the action of NGF-producing tumors seemed at first to be quantitively and qualitatively different from those elicited by implantation of additional limb pdmordia, this impression was later revised in a 1964 article:
In contrast to the tumor and the purified nerve growth factor, end organs have a very restricted field of action. End organs affect only the growth of nerve centers which provide their innervation. Such differences could be of a quantitative rather than qualitative order and could be correlated with differences in the production and release of growth factors in the two sets of experiments. Production and discharge may in fact be very limited in cases of implantation of limbs or additional organs. In suggesting that peripheral structures and the NGF might in the final analysis operate in a similar way, we do not imply that the release of growth factors should be the same; on the contrary, there is reason to befieve that each nerve cell type might be receptive to only one specific factor (Levi-Montalcini 1964, p. 11) . Some years later NGF was found to gain access to its target cells through membrane receptors present on the perikarya of target cells as well as on nerve endings. In addition, it was found that NGF gains entrance to the cytoplasmic compartment of the cell through retrograde axonal transport following binding and internalization. These two discoveries established beyond doubt the dual access of this protein molecule to its receptive nerve cells. More recently, considerable interest has developed in the humoral nonaxonal-mediated ~effects as these have become one of the most intensively investigated problems in ncurobiology. With the discovery that many nerve cells receive and dispatch messages over a distance in a hormonal fashion (besides conununicating locally through specific connections), the boundary between "endocrine" and "synaptic" action has narrowed. It is debatable whether such a line indeed still exists. The view of the brain as www.annualreviews.org/aronline Annual Reviews an "endocrine organ" (Guillemin 1978) testifies to this evolution in one the most firmly established dogmas of neurobiology. NGF made a most valuable contribution supporting this novel viewpoint in still another way, one that I consider in the final section.
THE NEUROTROPIC EFFECTS OF NGF AND THE ROLE OF ENVIRON-MENTAL FACTORS IN THE WIRING OF NEURONAL CIRCUITS
Is the formation of neuronal circuits in the central nervous system and the establishment of specific connections between nerve fibers and peripheral end organs rigidly programmed and unmodifiable, or are nerve fibers endowed with sufficient plasticity to allow for deviation from predetermined routes, in response to chemical signals issued during neurogenesis and regeneration from neuronal and non-neuronal cells? The existence of neurotropic signals has not been convincingly proved because a valid experimental approach to this problem has been lacking. The isolation and characterization of biochemical agents endowed with such properties in the developing organism and in the mature nervous system represents a continuing challenge to biochemists. A novel and most valuable approach to this problem became available with the discovery of NGF. Thus, a century-old problem, the hypothesis first proposed by Cajal that exogenous humoral factors play a role in guiding nerve fibers toward their matching cells, is now receiving increasing attention and direct support from the demonstration that NGF exerts a clear neurotropic effect on adrenergic nerve fibers both in vivo and in vitro.
A WIDENING SPECTRUM OF ACTION FOR NGF AND THE NEUROEN-DOCRINE SYNDROME DUE TO ENDOGENOUS ANTIBODIES FOR NGF
A new and most revealing feature of the NGF properties has come to light with the discovery that neoplastic pheochromocytoma cells and immature chromaffin cells undergo transformation into sympathetic neurons upon administration of NGF in vitro and in vivo. This discovery has made available a unique model system to study nerve cell growth and differentiation processes under ideal environmental conditions. At the same time, the recognition that the action of NGEis broader than was at first envisaged prompted a search for other putative target cells. Causes of stunted growth, hypothyroidism, and other morphological and behavioral alterations resulting from the treatment with NGF antiserum still cannot be traced to the cells or system(s) impaired by antibodies NGF. In addition, it is unclear whether these multiple effects are due to inactivation of NGF or to inactivation of NGF-like cross-reacting protein molecules by the antiserum to NGF. The fact remains, however, that injecting antibodies to NGF produces this complex syndrome. That a large number of neuronal centers and circuits control or modulate the function of the neuro-endocrine system is a great incentive for pursuing these studies www.annualreviews.org/aronline Annual Reviews and to identify the neuronal or possibly non-neuronal cells responsible for the described effects.
These findings, in turn, raise another question of whether NGF may not display activity similar to that of the ever-increasing list of polypeptides endowed with important neurotransmitter or neuromodulator functions in the central nervous system and in the gastro-intestinal tract. In concluding with this rather bold hypothesis (which at present has no support from experimental evidence), I find encouragement in the statement by Huxley quoted at the beginning of this article, "Those who refuse to go beyond fact rarely get as far as fact."
Concluding Remarks
In 1954, shortly after NGF had led us away from the main road, Viktor Hamburger, to whom I give the major credit for opening the field of experimental neuroembryology, for devising rigorously controlled experiments, and for clarifying and refining concepts of neuron-to-target cell interaction, abandoned NGF to its fate and continued his route on the main road, making in the next two decades new and extremely important contributions in the area of developmental neurobiology (Hamburger 1977) . Two years ago, when NGF merged once again with the main road, Viktor, most welcomed, returned to NGF.
This biographic report of the prodigious deeds accomplished by NGF while we were chasing it along the side alley is dedicated with love and gratitude to Viktor.
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